EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Deep Brain Stimulation in Pediatric Populations: A Scoping Review of the Clinical Trial Landscape

Youngkyung Jung, Karim Mithani, Hrishikesh Suresh, Nebras Warsi, Irene E Harmsen, Sara Breitbart, Carolina Gorodetsky, Alfonso Fasano, Aria Fallah, Aristides Hadjinicolaou, Alexander Weil, George M Ibrahim

Stereotactic and Functional Neurosurgery · 04.01.2025 · 103 (2) · 132-144

DOI: 10.1159/000543289 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Stereotactic and Functional Neurosurgery, online erschienen am 04.01.2025. Verfasst von Youngkyung Jung und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada, jessica.jung@medportal.ca. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Deep Brain Stimulation, Drug Resistant Epilepsy, Dystonia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

There has been rapid advancement in the development of deep brain stimulation (DBS) as a treatment option for adults for neurological and neuropsychiatric conditions. Here, we present a scoping review of completed and ongoing clinical trials focused on DBS in pediatric populations, highlighting key knowledge gaps.

Methods

Three databases (PubMed, OVID, and Embase) and the clinicaltrials.gov registry were queried to identify clinical trials for DBS in pediatric cohorts (age ≤18 years). Prospective and retrospective case series were excluded. No restrictions were placed on the diagnoses or measured clinical outcomes. Individual patient demographics, diagnosis, DBS target, and primary endpoints were extracted and summarized.

Results

A total of 13 clinical trials were included in the final review, consisting of 9 completed trials (357 screened) and 4 ongoing trials (82 screened). Of the completed trials, 6 studied dystonia (both inherited and acquired; participants aged 4–18 years) and 3 studied drug-resistant epilepsy (participants aged 4–17 years). Among the 6 trials for dystonia, 5 used the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) as the primary endpoint. There were a total of 18 adverse events documented across 63 participants, with 5 of 9 studies reporting adverse events. Ongoing clinical trials are evaluating DBS for dystonia (N = 2), epilepsy (N = 1), and self-injurious behavior (N = 1).

Conclusions

This scoping review summarizes the landscape of clinical trials for DBS in children and youth. In dystonia, further research is warranted with more relevant pediatric outcome measures and for understudied patient subgroups and targets. There are also significant gaps in our understanding of evaluating the role of DBS in other neurological and neurodevelopmental disorders in pediatric populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicDeep Brain StimulationDrug Resistant EpilepsyDystoniaAdolescentChildChild, PreschoolHumansTreatment Outcome

Stichwörter der Autor:innen

Clinical trialDeep brain stimulationPediatrics

Autor:innen und Institutionen

  • Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada, jessica.jung@medportal.ca.
  • Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada.
  • Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Division of Neurosurgery, Department of Surgery, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
  • Division of Neurosurgery, University of Alberta, Edmonton, Alberta, Canada.

Zitieren

APA

Jung, Y., Mithani, K., Suresh, H., Warsi, N., Harmsen, I. E., Breitbart, S., Gorodetsky, C., Fasano, A., Fallah, A., Hadjinicolaou, A., Weil, A., & Ibrahim, G. M. (2025). Deep Brain Stimulation in Pediatric Populations: A Scoping Review of the Clinical Trial Landscape. Stereotactic and Functional Neurosurgery, 103(2), 132-144. https://doi.org/10.1159/000543289

Vancouver

Jung Y, Mithani K, Suresh H, Warsi N, Harmsen IE, Breitbart S, et al. Deep Brain Stimulation in Pediatric Populations: A Scoping Review of the Clinical Trial Landscape. Stereotactic and Functional Neurosurgery. 2025;103(2):132-144. doi:10.1159/000543289

BibTeX
@article{Jung2025,
  author = {Jung, Youngkyung and Mithani, Karim and Suresh, Hrishikesh and Warsi, Nebras and Harmsen, Irene E and Breitbart, Sara and Gorodetsky, Carolina and Fasano, Alfonso and Fallah, Aria and Hadjinicolaou, Aristides and Weil, Alexander and Ibrahim, George M},
  title = {Deep Brain Stimulation in Pediatric Populations: A Scoping Review of the Clinical Trial Landscape},
  journal = {Stereotactic and Functional Neurosurgery},
  year = {2025},
  volume = {103},
  number = {2},
  pages = {132--144},
  doi = {10.1159/000543289}
}
Kostenlos starten →